Peel Therapeutics Inc.

Salt Lake City, UT

UEI
G1X8J9LJZM78
CAGE
7RF06
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
48 S Rio Grande St, Salt Lake City, UT 84101, USA
Website
peeltx.com
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Selection of a lead candidate for the development of a novel anti-inflammatory therapeutic R43AI155239 National Institute of Allergy and Infectious Diseases (NIH) $899,024
In vitro and in vivo evaluation of elephant P53 (EP53) protein nanoparticles for pediatric osteosarcoma R41CA221653 National Cancer Institute (NIH) $300,465

Quick answers

Is Peel Therapeutics Inc. registered in SAM.gov?

Yes. Peel Therapeutics Inc.'s SAM.gov registration is active through June 10, 2027.

What is Peel Therapeutics Inc.'s most recent federal award?

Peel Therapeutics Inc.'s most recent federal grant award is Selection of a lead candidate for the development of a novel anti-inflammatory therapeutic (R43AI155239), from National Institute of Allergy and Infectious Diseases (NIH), on April 15, 2021.

On GovTribe

See Peel Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login